DBITE

US trademark, USPTO serial 97341385

"DBITE" is a pending US trademark filing (serial 97341385), owned by Amgen Research (Munich) GmbH, filed March 31, 2022.

Get an email when this status changes

We email you about office actions, publication and registration for free, and we check after each USPTO data update.

Sign in to watch

Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.

Filing details

StatusPending
Serial number97341385
Filing dateMarch 31, 2022
OwnerAmgen Research (Munich) GmbH (2 filings)
NICE classes Class 5, Class 9, Class 16, Class 35, Class 42

Goods and services

Medicaments, namely, polypeptides, for use in the treatment of tumorous diseases, cancer, allergies, autoimmunity, inflammation, osteoporosis, graft versus host diseases, transplant rejection, cardiovascular diseases, metabolic diseases, neurological diseases, and minimal residual diseases

Is "DBITE" available to trademark? →

Source and method

Built from public USPTO trademark records via WikiTrademarks. We match by exact wording, whole-word, phonetic sound-alike, and fuzzy look-alike, scoped by NICE class. Data reflects the most recent USPTO import. Last updated November 20, 2026.

Cite this page: WikiTrademarks, "DBITE trademark (serial 97341385)", https://wikitrademarks.com/trademark/97341385/dbite (accessed November 20, 2026).